Sant P. Chawla, M.D., FRACP
Sant P. Chawla, M.D., is director of the Cancer Center of Southern California in Santa Monica, California, a comprehensive cancer treatment and clinical research facility. Dr. Chawla is medically licensed in Texas and California, and his medical board certification is in Medical Oncology and Internal Medicine. In additional to his director’s role at the Cancer Center, Dr. Chawla is a medical oncologist at Cedars-Sinai Comprehensive Cancer Center and an adjunct associate professor at Stanford University and the University of Texas, M.D. Anderson Cancer Center. He holds clinical faculty positions at prestigious cancer facilities, including USC, UCLA, and the John Wayne Cancer Institute at St. John’s Hospital, Santa Monica, California.
Dr. Chawla combines patient care with his groundbreaking research in pancreatic carcinoma, gynecologic tumors, breast cancer, glioblastoma, malignant peripheral nerve sheath tumors, lung cancer and gastrointestinal tumors. He is internationally recognized as a pioneering physician who’s received numerous accolades and recognition for his work in sarcoma and is internationally recognized as a leading authority in treatment and clinical research in sarcoma therapy and bone and soft-tissue sarcomas. Dr. Chawla’s work can be credited as the foundation of numerous other breakthroughs in malignant tumor treatment.
Dr. Chawla’s achievements in clinical research started in the 1980s with his pioneering work for young sarcoma patients. His research led to the development of a limb-saving treatment for osteosarcoma replacing amputation as the primary treatment. In the years since, Dr. Chawla has led over 60 clinical trials for cancer drugs with many of them approved by the EMA and FDA. In fact, the center recently completed a breakthrough Phase II trial for Aldoxorubicin (second line for soft tissue sarcomas) which reported an increase in progression-free and overall survival rates without any observed cardiotoxicity.
The doctor’s medical education began in his home country of India where he received his medical degree and served his residency in Internal Medicine at the All India Institute of Medical Sciences in New Delhi. Dr. Chawla continued his education in New Zealand at the Auckland Hospital in Auckland, for his specialization in medical oncology. Next, he completed his fellowship in medical oncology at New Zealand’s Fellow Royal Australasian College of Physicians (F.R.A.C.P.). Recognizing his outstanding academic accomplishments, the prestigious M.D. Anderson Cancer Center of the University of Texas invited him to continue his fellowship in oncology. M.D. Anderson is internationally recognized for excellence in malignant tumor patient care, research, education, and prevention. M.D. Anderson’s reputation as the top-ranked cancer hospital in the United States is based on its numerous and extraordinary research-based contributions benefiting people everywhere. M.D. Anderson is recognized as the leader in innovative malignant tumor therapy, and it is here that Dr. Chawla learned and enhanced his own understanding of the disease, preparing him for a pioneering career in sarcoma treatment and research.
Learn more about Dr Erlinda Maria Gordon.